Literature DB >> 23546802

Quantum-chemical approach to determining the high potency of clorgyline as an irreversible acetylenic monoamine oxidase inhibitor.

Matic Pavlin1, Janez Mavri, Matej Repič, Robert Vianello.   

Abstract

Density functional theory calculations were employed to investigate the nature of chemical bond formation between the flavin co-factor of the enzyme monoamine oxidase (MAO) and its irreversible acetylenic inhibitor clorgyline in its terminally deprotonated anionic form. Since MAOs regulate the level of neurotransmitters in living cells, this reaction is pharmacologically relevant for treating depression and other mood disorders. The results revealed that this pathway is associated with the activation free energy of ΔG act (#) = 17.4 kcal mol(-1), which, together with our previous results, suggests that clorgyline is intrinsically a more effective MAO inhibitor than antiparkinsonian drugs rasagiline and selegiline considering the preferred MAO isoforms in each case, thus displaying a trend in agreement with experimental data. The reaction is facilitated by the pronounced electrophilic character of the flavin moiety, due to its ability to efficiently accommodate excess negative charge from the approaching anionic inhibitor through resonance effect. The investigated mechanism was additionally validated by the inspection of the geometry of the flavin moiety in the formed adduct, which exhibit distortion from planarity consistent with experimental observations. These results offer valuable insight for mechanistic studies on other flavoenzymes and for the design of new antidepressants and antiparkinsonian drugs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546802     DOI: 10.1007/s00702-013-1016-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  39 in total

Review 1.  The therapeutic potential of monoamine oxidase inhibitors.

Authors:  Moussa B H Youdim; Dale Edmondson; Keith F Tipton
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

2.  Quantum chemical modeling of enzymatic reactions: the case of histone lysine methyltransferase.

Authors:  Polina Georgieva; Fahmi Himo
Journal:  J Comput Chem       Date:  2010-06       Impact factor: 3.376

3.  Potentiation of ligand binding through cooperative effects in monoamine oxidase B.

Authors:  Daniele Bonivento; Erika M Milczek; G Reid McDonald; Claudia Binda; Andrew Holt; Dale E Edmondson; Andrea Mattevi
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

4.  Functional role of the "aromatic cage" in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins.

Authors:  Min Li; Claudia Binda; Andrea Mattevi; Dale E Edmondson
Journal:  Biochemistry       Date:  2006-04-18       Impact factor: 3.162

5.  Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.

Authors:  Irene Bolea; Jordi Juárez-Jiménez; Cristóbal de Los Ríos; Mourad Chioua; Ramón Pouplana; F Javier Luque; Mercedes Unzeta; José Marco-Contelles; Abdelouahid Samadi
Journal:  J Med Chem       Date:  2011-11-15       Impact factor: 7.446

6.  Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.

Authors:  D A Di Monte; L E DeLanney; I Irwin; J E Royland; P Chan; M W Jakowec; J W Langston
Journal:  Brain Res       Date:  1996-10-28       Impact factor: 3.252

Review 7.  Monoamine oxidase: from genes to behavior.

Authors:  J C Shih; K Chen; M J Ridd
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

8.  Mechanistic analysis of a suicide inactivator of histone demethylase LSD1.

Authors:  Lawrence M Szewczuk; Jeffrey C Culhane; Maojun Yang; Ananya Majumdar; Hongtao Yu; Philip A Cole
Journal:  Biochemistry       Date:  2007-05-19       Impact factor: 3.162

9.  Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues.

Authors:  Frantisek Hubálek; Claudia Binda; Min Li; Yaacov Herzig; Jeffrey Sterling; Moussa B H Youdim; Andrea Mattevi; Dale E Edmondson
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

Review 10.  Redox control of protein conformation in flavoproteins.

Authors:  Toshiya Senda; Miki Senda; Shigenobu Kimura; Tetsuo Ishida
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

View more
  6 in total

Review 1.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

Review 2.  The Chemistry of Neurodegeneration: Kinetic Data and Their Implications.

Authors:  Matic Pavlin; Matej Repič; Robert Vianello; Janez Mavri
Journal:  Mol Neurobiol       Date:  2015-06-18       Impact factor: 5.590

3.  Computational Chemistry and Molecular Modeling of Reversible MAO Inhibitors.

Authors:  Kemal Yelekçi; Safiye Sağ Erdem
Journal:  Methods Mol Biol       Date:  2023

Review 4.  The Use of Multiscale Molecular Simulations in Understanding a Relationship between the Structure and Function of Biological Systems of the Brain: The Application to Monoamine Oxidase Enzymes.

Authors:  Robert Vianello; Carmen Domene; Janez Mavri
Journal:  Front Neurosci       Date:  2016-07-15       Impact factor: 4.677

5.  Evidence for a Cyanine Link Between Propargylamine Drugs and Monoamine Oxidase Clarifies the Inactivation Mechanism.

Authors:  Alen Albreht; Irena Vovk; Janez Mavri; Jose Marco-Contelles; Rona R Ramsay
Journal:  Front Chem       Date:  2018-05-28       Impact factor: 5.221

6.  Path Integral Calculation of the Hydrogen/Deuterium Kinetic Isotope Effect in Monoamine Oxidase A-Catalyzed Decomposition of Benzylamine.

Authors:  Mateusz Z Brela; Alja Prah; Marek Boczar; Jernej Stare; Janez Mavri
Journal:  Molecules       Date:  2019-11-28       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.